Recent Finacing
Recent Raise
NuPathe develops Zelrix, a four-hour battery-powered iontophoretic transdermal patch that delivers sumatriptan and controls delivery to reduce systemic side effects; also developing NP201 for Parkinson's.
Focus Areas
Recent Investors
Funding round
Investors